VRTX Competitors - Vertex Pharmaceuticals Incorporated logo

VRTX Competitors

Vertex Pharmaceuticals Incorporated

$538.60
-$4.02(-0.74%)
62
Overall
60
Value
63
Tech
63
Quality
How is this score calculated?
Market Cap
$136.56B
Volume
750.52K
52W Range
$410.50 - $568.67
Target Price
$589.79

VRTX competitors: GILD, ABBV, JNJ, BMY, MRK. Vertex Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.

VRTX Competitors Compared

CompanyPriceMarket capEPS est. (current yr)Dividend yieldMarketXLS Rank
GILD Gilead Sciences, Inc.$168.26$208.31B$-0.981.93%68
ABBV AbbVie Inc.$295.68$520.47B$13.982.34%58
JNJ Johnson & Johnson$286.77$682.52B$11.121.84%62
BMY Bristol-Myers Squibb Company$63.65$127.39B$6.443.96%69
MRK Merck & Co., Inc.$147.46$362.27B$2.782.31%69
ABCD
1SymbolPriceChangeVol
2VRTX$538.60-0.7%750.52K
3
4
5
6

Get Vertex Pharmaceuticals Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.